Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IC2O
|
|||
| Former ID |
DNC002379
|
|||
| Drug Name |
Anti-miR-191 modified oligonucleotide
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Hepatocellular carcinoma [ICD-11: 2C12.02; ICD-10: C22.0; ICD-9: 155] | Investigative | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | microRNA hsa-miR-191 (MIR191) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res. 2010 Oct 15;70(20):8077-87. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.